Ipca Labs Q3 net declines 70pc at Rs 42 cr

By: |
New Delhi | February 07, 2015 7:26 PM

Drug firm Ipca Laboratories today posted 70.14 per cent decline in net profit at Rs 41.53 crore...

Drug firm Ipca Laboratories today posted 70.14 per cent decline in net profit at Rs 41.53 crore for the third quarter ended December 31, 2014.

The company had posted a net profit of Rs 139.12 crore during the same period of previous fiscal.

Net sales of the company declined to Rs 734.13 crore during the quarter, as against Rs 821.99 crore during the same period of previous financial year, Ipca Laboratories Ltd said in a filing to the BSE.

For the nine months ended December 31, 2014, the company posted a net profit of Rs 248.32 crore, compared to Rs 340.34 crore during the same period of previous fiscal.

 

Get live Stock Prices from BSE, NSE, US Market and latest NAV, portfolio of Mutual Funds, Check out latest IPO News, Best Performing IPOs, calculate your tax by Income Tax Calculator, know market’s Top Gainers, Top Losers & Best Equity Funds. Like us on Facebook and follow us on Twitter.

Financial Express is now on Telegram. Click here to join our channel and stay updated with the latest Biz news and updates.

Next Stories
1NCLAT seeks fresh NCLT order against senior executives of Videocon Telecom
2ICICI Lombard Q2 net income rises to Rs 446 cr as COVID claims dip
3Increasing number of organisations concerned about existing data protection solutions: Report